Action 7
Prioritize the review of Pediatric Study Plans (PSPs) and Paediatric Investigation Plans (PIPs) for paediatric ARVs on the list of PADO priority products over lower priority drugs.
Committed by:
SRAs

Prioritize the review of Pediatric Study Plans (PSPs) and Paediatric Investigation Plans (PIPs) for paediatric ARVs on the list of PADO priority products over lower priority drugs.

SRAs

-

-

Milestone 7.1.1

Develop more effective ways to prioritize PADO products within current legal frameworks

-

GAP-f members developing proposals to communicate to FDA and EMA

-

Document (s)

-

-

-

-

Sub-action 7.1
Sub-Actions & Milestones

Updates

Notes

Responsible